Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001209191-23-005420

CFO acquired 1,834 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lamothe Jeffrey G. CFO 2023-01-29 Option exercise +1,834 9,026 D
Derivatives
Lamothe Jeffrey G. CFO 2023-01-29 Option exercise · Restricted Stock Unit −1,834 1,833 D
Loading xslF345X03/doc4.xml…